SHINVA(SH:600587) Xin Lang Cai Jing·2025-09-12 07:36Company Overview - Xinhua Medical is located in Zibo, Shandong Province, established on April 18, 1993, and listed on September 27, 2002. The company primarily engages in medical devices and pharmaceutical equipment, with a business system that includes medical trade and services [1]. Financial Performance - For the first half of 2025, Xinhua Medical reported operating revenue of 4.79 billion yuan, a year-on-year decrease of 7.64%. The net profit attributable to the parent company was 386 million yuan, down 20.35% year-on-year [2]. - As of June 30, 2025, the company had a total of 39,300 shareholders, an increase of 0.82% from the previous period. The average circulating shares per person were 15,386, a decrease of 0.81% [2]. Stock Performance - On September 12, Xinhua Medical's stock price fell by 2.06%, closing at 16.18 yuan per share, with a trading volume of 252 million yuan and a turnover rate of 2.55%. The total market capitalization was 9.816 billion yuan [1]. - Year-to-date, the stock price has decreased by 1.34%, with a decline of 1.22% over the last five trading days, a drop of 7.91% over the last 20 days, and an increase of 10.44% over the last 60 days [1]. Revenue Composition - The revenue composition of Xinhua Medical is as follows: medical device manufacturing accounts for 35.16%, medical trade products 31.23%, pharmaceutical equipment 24.43%, medical services 7.05%, and others 2.12% [1]. Shareholder Information - As of June 30, 2025, the top ten circulating shareholders included Huabao Zhongzheng Medical ETF, holding 16.0931 million shares, an increase of 196,600 shares from the previous period. Hong Kong Central Clearing Limited was the fourth-largest shareholder, holding 7.9202 million shares, an increase of 413,000 shares [3]. Dividend Distribution - Since its A-share listing, Xinhua Medical has distributed a total of 812 million yuan in dividends, with 455 million yuan distributed over the past three years [3].